Skip to content

Drug interactions

Fingolimod + Ofatumumab sc

Severity: Moderate

Fingolimod and Ofatumumab sc: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs reduce immune function, so using them together or in close sequence may raise the risk of infection. Fingolimod's effect on lymphocyte counts persists for weeks after it is stopped, which matters when switching therapy.

What this interaction means in plain words

Fingolimod and Ofatumumab sc can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Additive immunosuppression from lymphocyte sequestration by fingolimod and B-cell depletion by ofatumumab.

What to do

Avoid overlapping use where possible and allow for fingolimod's pharmacodynamic washout when switching. Monitor for infection and check lymphocyte and B-cell counts.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fingolimod and Ofatumumab sc, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fingolimod with Ofatumumab sc?

MediHelp rates the interaction as moderate. Fingolimod and Ofatumumab sc can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs reduce immune function, so using them together or in close sequence may raise the risk of infection. Fingolimod's effect on lymphocyte counts persists for weeks after it is stopped, which matters when switching therapy.

How serious is the interaction between Fingolimod and Ofatumumab sc?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid overlapping use where possible and allow for fingolimod's pharmacodynamic washout when switching. Monitor for infection and check lymphocyte and B-cell counts.

What other medicines interact with Fingolimod?

MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in